Barely Significant

Excerpts

3,862 sentences · 1 filter applied

The PARP inhibitor ABT-888 (Veliparib) showed a trend toward increased activity, with case reports and early-phase studies suggesting that tumors harboring homologous recombination repair deficiencies, particularly BRCA2 alterations, may be more susceptible; however, evidence in prostate cancer remains limited ( 31 ).
Discussion In this single-center randomized controlled trial evaluating patients with incomplete immune reconstitution early after HSCT, CCP administration showed a trend toward delaying the time to COVID-19 infection but did not significantly reduce the cumulative incidence within one month after the last CCP infusion.